Blair William & Co. IL Sells 120 Shares of Humana Inc. $HUM

Blair William & Co. IL reduced its position in Humana Inc. (NYSE:HUM) by 2.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,494 shares of the insurance provider’s stock after selling 120 shares during the period. Blair William & Co. IL’s holdings in Humana were worth $1,099,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after acquiring an additional 1,143,662 shares during the period. Dodge & Cox grew its stake in shares of Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock valued at $2,845,830,000 after purchasing an additional 557,175 shares during the period. Pzena Investment Management LLC grew its stake in shares of Humana by 6.1% during the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider’s stock valued at $1,013,133,000 after purchasing an additional 219,541 shares during the period. Davis Selected Advisers boosted its holdings in shares of Humana by 3.3% in the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider’s stock worth $616,873,000 after buying an additional 74,434 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC boosted its holdings in shares of Humana by 1.6% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider’s stock worth $327,293,000 after buying an additional 19,613 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Wells Fargo & Company raised their price objective on shares of Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Wolfe Research raised their price objective on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. Mizuho raised their price objective on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Barclays dropped their price objective on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating on the stock in a report on Friday, October 3rd. Finally, Piper Sandler dropped their price objective on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $297.58.

Humana Trading Up 0.3%

Humana stock opened at $262.29 on Thursday. The stock has a market cap of $31.55 billion, a P/E ratio of 20.13, a PEG ratio of 1.53 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The firm’s 50 day moving average price is $280.15 and its 200-day moving average price is $258.14.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter in the prior year, the firm posted $6.96 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio (DPR) is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.